Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC‐1 tumor‐bearing mice with PD‐1 blockade by modulating macrophage heterogeneity and the activation of CD8(+) T cells in the tumor microenvironment

OBJECTIVES: Developing a vaccine formula that alters the tumor‐infiltrating lymphocytes to be more immune active against a tumor is key to the improvement of clinical responses to immunotherapy. Here, we demonstrate that, in conjunction with E7 antigen‐specific immunotherapy, and IL‐10 and PD‐1 bloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Guoying, Yang, Xiaodan, Li, Junjie, Wu, Xiaolian, Liu, Ying, Li, Hejie, Chen, Shu, Fogarty, Conor E, Frazer, Ian H, Chen, Guoqiang, Liu, Xiaosong, Wang, Tianfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369845/
https://www.ncbi.nlm.nih.gov/pubmed/34429969
http://dx.doi.org/10.1002/cti2.1335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369845/
https://www.ncbi.nlm.nih.gov/pubmed/34429969
http://dx.doi.org/10.1002/cti2.1335

Ejemplares similares